Countagen jobs and careers

About Countagen

Countagen is a Stockholm-based biotechnology company comited to accelerate the pace of gene editing advancements by providing high-resolution gene editing characterization. Out technology platform, LockSeq, is a novel targeted NGS library preparation based on a unique gap-fill chemistry that minimizes target dropouts and amplification bias, enabling routine and standardized gene editing characterization at every stage of development. The LockSeq Advantage: - Simultaneous Indel Profiling: Profile and validate hundreds of genomic loci in a single reaction. - High Sensitivity: Robust detection of on- and off-target edits down to 0.1% frequency. - Broad Compatibility: Compatibility across sequencing platforms. - Cost-Efficient Scalability: Scale panels and samples with minimal target dropout and uniform target capture. 📍 Based in the SciLifeLab / Karolinska Institutet ecosystem, Solna.

Founded in 2020 by Felix Neumann, Mats Nilsson and Mårten Winge.